Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

51.74
BATS BZX Real-Time Price
As of 1:20pm ET
 +0.72 / +1.41%
Today’s Change
38.26
Today|||52-Week Range
52.64
+7.97%
Year-to-Date

Today’s Trading

Previous close51.02
Today’s open51.02
Day’s range50.96 - 51.83
Volume154,566
Average volume (3 months)3,187,697
Market cap$25.3B
Dividend yield0.73%
Data as of 1:20pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+7.44%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)-0.42%
P/E ratio40.5
Price/Sales5.05
Price/Book23.76

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.62+1.32%
ALXNAlexion Pharmaceutic...+2.08+1.73%
VRTXVertex Pharmaceutica...+2.46+2.89%
MYLMylan NV-0.23-0.60%
Data as of 1:20pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.46
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts

Search for Jobs